Podnos Yale 4

What Happened Podnos Yale, Chief Medical Officer of Oncology Institute, disposed of 3,420 shares on March 17, 2026, at $3.59 per share, for a total proceeds of $12,278. The filing shows this was a disposition (transaction code J) and the sale was executed to cover tax liabilities from the vesting of an RSU award.

Key Details

• Transaction date: March 17, 2026; Price: $3.59; Shares: 3,420; Total: $12,278.
• Footnote F1: Issuer executed the sale to cover tax liabilities arising from RSU vesting on March 17, 2026 (sell-to-cover).
• Shares owned after the transaction: not specified in the provided filing summary—see the Form 4 for full beneficial ownership details.
• Filing date: March 18, 2026 (appears timely; not marked late).

Context This was a sell-to-cover tied to RSU vesting (a routine tax-withholding sale), not an open-market discretionary sale. Such transactions are common when restricted stock units vest and do not necessarily signal insider sentiment about the company. Purchases generally carry more weight as a positive signal than routine withholding sales.